Melanoma Research

Journal Logo

December 2022 - Volume 32 - Issue 6

  • F.J. Lejeune
    W.J. Storkus
  • 0960-8931
  • 1473-5636
  • 6 issues / year
  • 28 of 68 Dermatology
    95 of 139 Medicine, Research & Experimental
    172 of 245 Oncology
  • 3.199

Current Issue Highlights


Resistance to anti-PD1 therapies in patients with advanced melanoma: systematic literature review and application of the Society for Immunotherapy of Cancer Immunotherapy Resistance Taskforce anti-PD1 resistance definitions

Shui, Irene M.; Scherrer, Emilie; Frederickson, Andrew; More

Melanoma Research. 32(6):393-404, December 2022.


Basic Research


Translational Research


Clinical Research


Neurological adverse effects associated with anti-PD1 antibodies alone or in combination with ipilimumab: a multicenter case series

Smith, Jessica Louise; Menzies, Alexander M.; Cohen, Justine V.; More

Melanoma Research. 32(6):451-459, December 2022.

Long-term survival of patients with advanced melanoma treated with BRAF-MEK inhibitors

Ismail, Rawa K.; Suijkerbuijk, Karijn P.M.; de Boer, Anthonius; More

Melanoma Research. 32(6):460-468, December 2022.


Clinical Research